Indirubin (Compound)

Synonyms:Indirubin, 479-41-4, Indigo Red, Couroupitine B, Indigopurpurin, 906748-38-7, (Z)-[2,3'-biindolinylidene]-2',3-dione, UNII-V86L8P74GI, NSC 105327, NSC-105327, 3-(3-oxo-1H-indol-2-ylidene)-1H-indol-2-one, (E)-[2,3'-biindolinylidene]-2',3-dione, C.I. 73200, 397242-72-7, UNII-1LXW6D3W2Z, 1LXW6D3W2Z, 2H-Indol-2-one, 3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, (Z)-[2,3 inverted exclamation mark -Biindolinylidene]-2 inverted exclamation mark ,3-dione, V86L8P74GI, 2-(2-hydroxy-1H-indol-3-yl)indol-3-one, MFCD00956441, [2,3'-Biindolinylidene]-2',3-dione, C.I. 75790, MFCD00221745, 3-(1,3-dihydro-3-oxo-2h-indol-2-ylidene)-1,3-dihydro-2h-indol-2-one, SMR000466311, BRN 0088279, Isoindirubin, Isoindirubine, Isoindogotin, Indirubin [MI], Indirubin,(S), Indirubin- Bio-X, INDARUBICIN, CPD000466311, Indirubin derivative, 1, BiomolKI_000069, EM-A05-INDIRUBIN, [.DELTA.2,3-dione, Indirubin 3E-form [MI], BiomolKI2_000073, (3Z)-3-(3-oxoindolin-2-ylidene)indolin-2-one, (delta(sup 2,3')-BIINDOLINE)-2',3-DIONE, SCHEMBL27678, BMK1-G9, BSPBio_001110, KBioGR_000450, KBioSS_000450, 5-24-08-00507 (Beilstein Handbook Reference), MLS000759416, MLS001424211, MLS002473308, MLS006010732, CHEMBL35349, BDBM7392, CHEMBL259664, SCHEMBL9899338, (3E)-3-(3-oxo-1H-indol-2-ylidene)-1H-indol-2-one, CHEMBL1276127, CHEMBL3185783, CHEBI:92322, cid_5318433, KBio2_000450, KBio2_003018, KBio2_005586, KBio3_000839, KBio3_000840, EX-A347, Bio2_000395, Bio2_000875, HMS1362H11, HMS1792H11, HMS1990H11, HMS2051H20, HMS2234G06, HMS3369O15, HMS3393H20, HMS3403H11, HMS3656O13, ACT03264, AMY39890, BCP28869, HY-N0117, AC1180, BDBM50023867, BDBM50349806, FD9058, NSC105327, s2386, ZINC18825333, 2H-Indol-2-one,3-(1,3-dihydro-3-oxo-2H-indol-2-ylidene)-1,3-dihydro-, AKOS015895136, AKOS028108775, AKOS032455876, ZINC100015416, AC-8003, BCP9000788, CCG-100673, CCG-101058, CCG-267073

Pubchem:PUBCHEM:5318433

Id:10177

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Indirubin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Indirubin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Indirubin.

Results found

Linked to

	Label	Description
	BRD-K17894950-001-14-3 Substance (Entity type)	A Substance
	indirubin (8c52c503-af8d-4148-a61f-ca16023aed13) Collection (Entity type)	Metadatata for indirubin
	indirubin (f8bd3cf3-1592-4c79-9f79-bd564a82c933) Collection (Entity type)	Metadatata for indirubin
	indirubin (9f8e3206-31e6-40b0-b238-4f537e2870cd) Collection (Entity type)	Metadatata for indirubin
	indirubin negatively regulates POSTN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indirubin in similarity relationship with Danegaptide Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indirubin positively regulates UCHL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indirubin negatively regulates LUM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indirubin negatively regulates MAP7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	indirubin negatively regulates COL9A2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS